Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.

D.L. Kreb; K. Bosscha; M.F. Ernst; M.J.C.M. Rutten; G.J. Jager; P.J. van Diest; J.C. van der Linden

Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.

Translated title of the contribution: Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.

D.L. Kreb, K. Bosscha, M.F. Ernst, M.J.C.M. Rutten, G.J. Jager, P.J. van Diest, J.C. van der Linden

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.
Original language	Undefined/Unknown
Pages (from-to)	404-412
Number of pages	9
Journal	Biotechnic and Histochemistry
Volume	86
Issue number	6
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/20950219

Cite this

@article{be25938ad5a64119be87be11d241df9a,

title = "Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.",

author = "D.L. Kreb and K. Bosscha and M.F. Ernst and M.J.C.M. Rutten and G.J. Jager and {van Diest}, P.J. and {van der Linden}, J.C.",

year = "2011",

language = "Undefined/Unknown",

volume = "86",

pages = "404--412",

journal = "Biotechnic and Histochemistry",

issn = "1052-0295",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.

AU - Kreb, D.L.

AU - Bosscha, K.

AU - Ernst, M.F.

AU - Rutten, M.J.C.M.

AU - Jager, G.J.

AU - van Diest, P.J.

AU - van der Linden, J.C.

PY - 2011

Y1 - 2011

M3 - Article

SN - 1052-0295

VL - 86

SP - 404

EP - 412

JO - Biotechnic and Histochemistry

JF - Biotechnic and Histochemistry

IS - 6

ER -